An Algorithmic Approach to Procedural Complications
Procedural ComplicationsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. David Ozog, chair of the dermatology department at Henry Ford Hospital. Watch as Dr. Ozog outlines his approach to handling complications from dermatology procedures. He believes communication may very well be the most important consideration, so hear how he keeps in touch with his patie …
Procedural Complications
Biologics and Immunomodulators for Immunobullous Diseases
Immunobullous DiseasesAt ODAC 2023, we had the opportunity to learn about the latest in treatments for blistering diseases from Dr. Karl Saardi, Associate Professor and Director of Inpatient Dermatology at George Washington University. We focused on the pemphigus and pemphigoid group of diseases, which we will review and summarize here. Pemphigus The pemphigus group of diseases is characterized by intraepidermal auto …
Immunobullous Diseases
What You Should Know About Ingredients in FDA-Approved Neuromodulators
neuromodulatorsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Terrance Keaney, assistant clinical faculty of dermatology at GW School of Medicine and Health Sciences, and Howard University. Dr. Keaney says there’s more to neuromodulators than the active protein -- other proteins in the vials could play a role in treatment effectiveness. Could eve …
neuromodulators
What’s New in Wound Healing
wound healingNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Hadar Lev-Tov, associate professor of clinical dermatology and cutaneous surgery at the University of Miami Miller School of Medicine. Watch as Dr. Lev-Tov shares some of the treatments that are emerging in wound healing. Find out why a beta blocker may be the most well-kept secret in he …
wound healing
Nonsurgical Treatment of Non-Melanoma Skin Cancers
Non-melanoma skin cancerThere are many procedural treatments that we have worked on finessing in dermatology, but for some patients with non-melanoma skin cancer, nonsurgical treatments should be discussed. We had the opportunity to review the strengths and weaknesses of nonsurgical treatment approaches for non-melanoma skin cancer and review the indications and future implications of these treatments at ODAC 2023 with D …
Non-melanoma skin cancer